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Abstract
Background: Premature Ovarian Insufficiency (POI) is classically defined as 4–6 months of cessation of menses
(amenorrhea) in women under 40, associated with menopausal level of serum gonadotropins FSH > 40 IU/L and
hypo-estrogenism and is also referred to as hypergonadotropic hypogonadism. This disorder can manifest as
primary amenorrhea without the onset of menses (menarche), or as secondary amenorrhea after menarche and
pubertal development. The diagnosis of this condition in Cameroon is sometimes difficult because of the high cost
of hormonal assays and the few laboratories offering these services.
Case presentation: The patient was a 38-year-old G2P0020, blood group O Rh positive, genotype AA and BMI
19 kg/m2 who came to our service because of secondary amenorrhea and infertility of 2 years’ duration. She has a
history of pulmonary tuberculosis that was treated in Cameroon. After laparoscopy and hormonal profile, the
diagnosis of premature ovarian insufficiency was reached. The woman underwent a successful donor egg in-vitro
fertilization cycle and delivered a female fetus. Two years later YE requested IVF with autologous eggs, which was
not possible, and since then she has remained with one child.
Conclusion: The diagnosis of premature ovarian insufficiency is difficult in Cameroon because of the high cost of
laboratory investigations and difficult access to the tests. In-vitro fertilization with donor egg is a better treatment
option. Unfortunately, it is not accessible to most Cameroonians because of lack of technical ability and the
existence of cultural and financial barriers.
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Background
The median age of natural menopause in African-
American women is 49.4 years. This is 6–12 months
lower than the average age for caucasian women,
50.1 years [1, 2]. However, 1% of women under the age
of 40 and 0.1% of women under 30 experience prema-
ture menopause [3]. Premature ovarian insufficiency
(POI) is classically defined as 4–6 months of cessation of
menses (amenorrhea) in women under 40, associated
with menopausal levels of serum gonadotropins FSH >
40 IU/L and hypo-estrogenism, also referred to as hyper-
gonadotropic hypogonadism. This disorder can manifest
as primary amenorrhea, without the onset of menses
(menarche) or as secondary amenorrhea after menarche
and pubertal development [4, 5]. The diagnosis of this
condition in Cameroon is sometimes difficult because of
the high cost of hormonal assays and the few laborator-
ies offering these services.
POI leads to infertility and hypo-estrogenism which
generates problems linked with the target organs that
contain estrogen receptors (osteoporosis, cardiovascular
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diseases, or neurodegenerative diseases). In current gy-
necologic practice, hypo-estrogenism can be managed
with hormone replacement therapy (HRT) that is given
until the age of physiological menopause. On the other
hand, fertility cannot be regained when the diagnosis of
POI (or end-stage POI) has been made [6, 7]. We report
here a case of secondary infertility due to premature
ovarian insufficiency (POI) treated by donor egg in-vitro
fertilization in Douala, Cameroon.
Case presentation
The patient was a 38-year-old G2P0020, blood group O
Rh positive, genotype AA with a BMI of 19 kg/m2. She
presented to our service because of secondary amenor-
rhea and infertility of 2 years’ duration. She had a history
of pulmonary tuberculosis that was treated for 6 months
in Cameroon with rifampicin, ethambutol, isonazide and
pyrazinamide for 2 months and rifampicin and isonazide
plus vitamin B to prevent peripheral neuropathy for a
further 4 months. There was no family history of prema-
ture ovarian insufficiency or auto-immune disease. Her
history was notable for laparoscopic surgery in Paris,
France, in 1998, where 2 small fibroids were removed
and biopsy done on both ovaries. Histology showed right
ovarian dystrophy with no primordial ovarian follicles or
corpus luteum scar, and uterine leiomyomata. There was
left ovarian atrophy with one primordial follicle and one
atretic follicle. The diagnosis of Stein-Leventhal syn-
drome was incorrectly made. Her hormonal profile done
in France, revealed an estradiol of 15ρg/ml, FSH levels
of 68.2 IU/ml and 92.03 IU/ml, LH 61.7 IU/ml and
43.91, and inhibin B 15ρg/ml (normal >45ρg/ml). Com-
plementary laboratory test results done in Cameroon re-
vealed Prolactin 91.57 mIU/l, T3 1.53 nmol/l, T4
90.68 nmol/ml, THS (ultra sensitive) 0.65 ng/ml and
Testosterone 0.06 ng/ml.
The patient underwent the progesterone challenge test
with Synergon® (progesterone, estrone) which was nega-
tive. The husband had normal semen parameters. The
diagnosis of premature ovarian insufficiency was discussed
and the couple was counseled to undergo egg donor
In-vitro fertilization.
After obtaining informed consent, we matched the an-
onymous donor-controlled ovarian stimulation cycle
with the recipient’s endometrial preparation. For this
purpose, we used the short agonist protocol (triptorelin
(Decapeptyl®) 0.1 mg/day plus menotropin (Menogon®)
150 IU/day) starting from the third day of the donor’s
cycle untill we obtained three leading follicules of 17–
18 mm in diameter. The donor was monitored with stand-
ard trans-vaginal sonography and serum estradiol levels.
We prepared the patient’s (recipient YE) endometrium
for embryo transfer with estradiol valerate (progynova®)
8 mg/day in three divided doses for 14 days starting
from the first day of the donors menses. A trans-vaginal
sonogram was performed every 3 days to monitor the
endometrial thickness until we obtained an endometrial
thickness of about 14 mm. The husband’s sperm was
prepared with the density gradient centrifugation as previ-
ously described [8–10]. A total of four fresh donor oocytes
were obtained and were inseminated and the patient (re-
cipient) began progesterone (utrogestan® vaginal tablets)
600 mg/day from the day of oocyte insemination. Two
fresh 8-cell (grade A) embryos were transferred to the
recipient YE (patient) on day 3 of insemination after the
standard IVF procedure. The remaining two (grade C)
embryos were discarded for lack of facilities for gamete
freezing at the time. (However, since 2012 our IVF centre
has the facilities to freeze gametes and embryos.)
After embryo transfer, the recipient continued with pro-
gesterone suppositories(utrogestan®) and estradiol valerate
(progynova®) and underwent her first plasma beta hCG
assay 2 weeks after embryo transfer. The test result was
positive, with a value of 248 IU/L. She underwent a
trans-vaginal ultrasound scan 2 weeks after the positive
pregnancy test that revealed an intra-uterine gestational
sac of 13 mm diameter (Fig. 1). A repeat trans-vaginal
ultrasound scan done about 2 weeks from the latter
showed a singleton intrauterine pregnancy with a
crump-rump length of 17 mm corresponding to 8 weeks
1 day gestation Fig. 2).
Her pregnancy follow-up was uneventful until she
developed preterm labour at 36 weeks 4 days gestation
and fetal distress was diagnosed on cardiotocography.
She gave birth by cesarean section to a female baby who
weighed 2360 g. At cesarean section, the presentation
Fig. 1 Gestatational Sac of Patient at 6 weeks gestation
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was breech with two turns of nuchal cord. One and 5-
min Apgar scores were 8 and 10, respectively. The baby
was sent to the neonatal intensive care unit (NICU) for
follow up. Two years later, YE requested for IVF with au-
tologous eggs which, it was explained, was not possible.
She is now living with one child.
Discussion
Premature ovarian insufficiency is a difficult diagnosis to
make in current gynecologic practice in Cameroon. In
majority of cases the underlying cause is not identified.
The diagnosis of POI on this patient was based on sec-
ondary amenorrhea of 2 years’ duration and elevated
FSH (61.7 IU/ml and 92.03 IU/ml) on two occasions
8 weeks apart and low estrogen (<15ρg/ml) in a 38-year-
old lady. This unfortunate patient underwent laparos-
copy with ovarian biopsies, which in fact did confirm the
absence of follicles, but was not diagnosed correctly as
consistent with ovarian insufficiency. Her findings are
consistent with the literature [4, 5]. In this case, the pa-
tient had normal secondary sexual organ development
(regular menstrual patterns, hair distribution etc.) and
no physical signs of hyper-androgenism. There was no
family history of POI before the condition. She developed
secondary amenorrhea only after she was diagnosed and
treated for pulmonary tuberculosis.
Genital tuberculosis has been associated with men-
strual disorders [11] and premature ovarian insufficiency
[12]. A prior study evaluated the menstrual patterns of
120 women with genital tuberculosis diagnosed by
histopathology. The common menstrual disorder was
oligo-hypomenorrhea found in 54.0% cases, menorrhagia
in 19.0% cases, and post menopausal bleeding in 1.6%
cases. A history of amenorrhea was present in 14.3%
cases. There were 8 cases of secondary amenorrhea and
one case of primary amenorrhea [11]. A direct cause–ef-
fect relationship between tuberculosis and premature
ovarian insufficiency has not yet been established [13].
Most women with premature ovarian insufficiency re-
port seeing three or more different clinicians before
diagnosis. Furthermore, women with spontaneous pre-
mature ovarian insufficiency perceived a need for more
aggressive evaluation of secondary amenorrhea and oli-
gomenorrhea [12].
The major concern of this couple was infertility, espe-
cially given the age and parental status of the patient
(38 years old, with no living child). She may have been
counseled to wait for some years to obtain a spontan-
eous pregnancy as has been reported in other studies
[14, 15]. However, IVF with donor egg was immediately
proposed to this patient because of her advanced age
and because it is the treatment of choice for POI [16–18].
The Lagos University Teaching Hospital team of
Giwa-Osagie at al. were the first in Africa to produce
documented pregnancies through IVF in 1984 and 1986,
and a live birth in 1989. The successes from IVF at the
Lagos University team were the first in West, East and
Central Africa. Now all ART units performing IVF in
West, Central and East Africa are in the private sector,
or are incorporated as foundations [19]. However, egg-
donor IVF has been documented only in Nigeria [19]. In
Cameroon, there are two IVF centres in the private
sector in Douala [20], and a third centre that has just
been opened in the public sector in Yaounde. Despite
Fig. 2 Gestational Sac of Patient at 8 weeks 1 day gestation
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these centres, there has been no documented evidence
of donor egg IVF services in Cameroon in the existing
medical literature [19].
The cost of IVF in most sub-Saharan African countries
ranges between 2500 and 3500 USD including drugs [21].
This cost is prohibitive in a country where the monthly in-
come ranges between 21.83 and 94.54 USD [22, 23], and
where there is no insurance coverage for IVF as compared
to countries like Israel, France and Belgium that have
elaborate coverage [20]. Such rates constitute a hurdle
for infertile couples wishing to undergo IVF treatment.
There is need for a cost-effective, simplified, assisted
reproduction treatment protocol for low-income coun-
tries like Cameroon [24].
There is no formal egg donation program in
Cameroon. We usually pair a donor (woman ≤30 years
serologically tested and programmed for IVF) with a re-
cipient. The recipient pays for the IVF charges of the
donor with an additional fee of 423 USD irrespective of
the number of oocytes donated). The donor only pays
for the drugs used for ovarian hyperstimulation. This
helps in reducing the cost of the procedure for both the
donor and the recipient. This amount is small compared
with that reported by some centres in the USA [25].
In Cameroon, there is no legislation on the practice of
IVF. The IVF centre in Douala, Cameroon applies the
guidelines as practiced in France because we work in
collaboration with Dr Guy Casutto’s Drouot Laboratory
in Paris, France. Attitudes of users of IVF vary depend-
ing on cultural and especially religious backgrounds.
Cameroon has a variety of denominations that range
from Christianity through Islam to Animism. In 1987,
the Roman Catholic Church issued a document “Donum
vitae” which stated that IVF was illicit and was not to be
used by the faithful [20]. Roman Catholic Christians typ-
ically abide by that principle. Other religious groups
have different attitudes.
Another option for treatment of POI, is ovarian tissue
transplantation, which has been used between monozy-
gotic twins discordant for premature ovarian insufficiency.
After unsuccessful egg-donation therapy, the sterile
twin received a transplant of ovarian cortical tissue
from her sister by means of a mini-laparotomy. Within
three months of transplantation, the recipient’s cycles
resumed and serum gonadotropin levels fell to the nor-
mal range. During the second cycle, she conceived and
her pregnancy progressed uneventfully [26]. This was
not an option for the index patient as she did not have
a twin. Ovarian tissue transplantation has never been
attempted in Cameroon. This could, however, be a sub-
ject for further research.
IVF centres in sub-Saharan Africa (SSA) now practice
most of the ART procedures: artificial insemination with
husband’s sperm (AIH), artificial insemination with donor
sperm (AID), IVF, intra-cytoplasmic sperm injection
(ICSI), Donor gamete IVF and freezing (cryopreservation)
of gametes like most centres in Europe and USA [19].
The major difference between IVF centres in SSA and
those in Europe and the USA is that centres in Europe and
the USA have the capacity to perform pre-implantation
genetic diagnosis [27, 28] and a larger number of IVF cycles
per annum. In a study of 21 countries in the ART register
in Europe, a total of 399 020 ART cycles were performed in
a population of 373.8 million, corresponding to 1067 cycles
per million inhabitants [29]. The take-home baby rate per
cycle is 26.6% in Europe and 40.7% in the USA [30], and
are greater than in SSA centres (50–159 cycles per annum,
take-home babies 10–15.8%) [19].
There is not only high cost of ART as compared to the
average income of Cameroonians, there is also lack of
knowledge about the different ART procedures (IUI and
IVF) and inaccessibility to IVF centres. All three IVF
centres in Cameroon are located in the two main cities,
Yaounde and Douala. It is difficult for the rural dwellers
to have access to these centres. Traditional beliefs and
customs may also play a role. Generally, what is not
known is accepted with difficulty. All these factors make
donor egg IVF a rare procedure in Cameroon. Further-
more, the country lacks qualified reproductive endocri-
nologists and embryologists, mainly because there is no
sustained training program for them. Most of the repro-
ductive endocrinologists in Cameroon have been trained
either in Europe or in the USA.
Finally, lawmakers and educators usually support re-
search and investment in other aspects of reproductive
health including contraception, HIV/AIDS prevention
and maternal mortality reduction. It is generally thought
that the problem of overpopulation can only be solved
by good family planning programs and education.
Therefore, some believe that the infertile couple should
be encouraged to courageously accept their condition of
childlessness rather than be offered intervention [31].
There is therefore little or no emphasis as regards infer-
tility and assisted reproduction in Cameroon.
The index patient came to our infertility clinic 2 years
later to seek for IVF with her own eggs because she
never resumed menstruation. It has been reported that
although an unknown donor was felt to be a much safer
option, as compared to adoption, in terms of protecting
the mother–child relationship, the lack of information
raised concerns about what genetic condition might
emerge in the child. There is wide variation in how
much women are preoccupied by the donor screening
and matching process [32]. However, we did not have
this problem with the index case.
Most of the ethnic cultures in Cameroon and in most
of SSA do not accept childlessness [19, 31]. To that effect,
traditionally, couples seek for children from relatives
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(a sister bearing a child with the husband of another sister
who could not conceive or a brother impregnating the
wife of an infertile brother, etc.). All these practices are
kept as family secrets, the reason being to maintain the
genetic constitution of the family and avoid hereditary
ailments like madness, drunkenness, etc. Cameroonian
society has easily adopted ART procedures. Nevertheless,
the offspring of this technology, including relatives and
friends, are usually blinded to the facts of their conception
[19, 31]. Furthermore, concerning adoption, it has been
reported that in Cameroon the level of knowledge is high
among the educated class but many women lack know-
ledge regarding how and where to go in order to effect an
adoption. The attitude towards adoption is favourable but
the practice of adoption is still limited [33].
Limitations
Some patients in Cameroon may not accept donor egg
IVF for cultural or religious reasons. This was not the
case with our patient. The cost of IVF (about 3279 USD)
per IVF cycle in Cameroon might be a limiting factor
for most couples, but our couple was of high socio-
economic standing and could readily afford the proced-
ure. For economic reasons, many patients are not able
to afford IVF in Cameroon. Hormonal and immuno-
logic diagnosis, including genetic studies of patients, is
a further limitation. Quite often, the tests cannot be
done in Cameroon, which means that the samples have
to be sent to Europe or to the USA for analysis. In the
case of our patient, some of the follow-up and diagnosis
was done in France. This led to higher cost and a longer
time to obtain the results and initiate treatment.
The strength of the case is that it conforms with the
current literature in that we transferred two fresh 8-cell
day 3 embryos to obtain a singleton pregnancy in one
cycle. Current practice recommends ideally single em-
bryo transfer (SET) in two consecutive cycles, although
two embryos transferred in one cycle affords the same
pregnancy rate but higher twinning rate [34–37].
Assisted reproductive technology (ART) is not popular
in Cameroon and in much of sub-Saharan Africa, the
main reason being the lack of equipment and trained
staff, and financial and cultural barriers. There is some
bias as some believe that a child obtained from ART is
not a normal child.
Conclusion
Premature ovarian insufficiency remains a dilenma in
Cameroon. The gold standard should be good counsel-
ling in favour of donor-egg IVF for those who require
children and can afford it, and HRT to avoid complica-
tions of hypoestrogenism in the long term. ART is not
accessible to most Cameroonians because of lack of
technical ability, and cultural and financial barriers.
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